Skip to main content

Table 1 General characteristics, atherosclerosis burden, acute phase management and medical treatments at discharge, grouped according to the depression status over a 9-month follow-up after ACS

From: High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome

 

No Depression 71.3%

Depression 28.7%

General characteristics

  

Mean Age ± sd (years)

49.0 ± 8.8

52.2 ± 9.2

Female gender (%)

6.4

16.0

Personal history of CV disease (%)

8.1

16.0

Family history of CV disease (%)

17.7

28.0

Personal history of depression (%)

37.1

88.0 **

Familial history of depression (%)

25.8

20.0

Live alone (%)

17.7

24.0

Widow(er)/divorcee/separated (%)

45.1

48.0

Low Socio-economic level (%)

8.0

16.0

Atherosclerosis Burden

  

Mean number of coronary vessels >50% stenosis

1.4+/−0.8

1.6+/−0.6

ABI < 0.9 (%)

11

7

Carotid stenosis >20% (%)

18.6

22.2

IMT > 0.7 mm (%)

63

60

ACS treatment

  

Revascularisation (%)

91.9

92.0

Conventional Treatment (%)

8.1

8.0

Post ACS medications at discharge

  

Beta-blocker and/or calcium antagonist

96.7%

96.0%

Cholesterol-lowering medication

93.5%

100.0%

Antiplatelet therapy or warfarin

100.0%

100.0%

ACE inhibitor or Angiotensin II receptor agonist

100.0%

96.0%

Combination of anti-ischemic/antiplatelet/Lipid-lowering drug

90.3%

96.0%

  1. *p values of tests comparing the “No depression” and “Depression” groups (Student’s t test for age, Chi square tests for proportions). * p < 0.05; ** p < 0.01.